Kidney Cancer Clinical Trial

Decision Aid (DA) for Renal Patients

Summary

The objective of this study is to understand how patients make decisions about treating their kidney masses, and to identify key values and preferences for treating their kidney masses. The study team will develop a decision aid (DA) using the decision-analytic model to communicate personalized benefit/harm estimates to patients and promote patient-centered treatment of renal tumors.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Male and female post-op and pre-op patients, ages 18 and older, diagnosed with a localized renal tumor up to 4 cm in diameter.
Patients scheduled for standard-of-care clinical exams with the NYU Urology Department

Exclusion Criteria:

Stage IV cancer of any type
Inability to provide informed consent
Vulnerable subjects will not be recruited

Study is for people with:

Kidney Cancer

Estimated Enrollment:

40

Study ID:

NCT05387863

Recruitment Status:

Recruiting

Sponsor:

NYU Langone Health

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

NYU Langone Health
New York New York, 10016, United States More Info
Stella Kang, MD
Contact
[email protected]
Justin Fogarty
Contact
[email protected]
Stella Kang, MD
Principal Investigator

How clear is this clinincal trial information?

Study is for people with:

Kidney Cancer

Estimated Enrollment:

40

Study ID:

NCT05387863

Recruitment Status:

Recruiting

Sponsor:


NYU Langone Health

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.